Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer

Overview of attention for article published in Frontiers in oncology, July 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,596 followers.

RT @AnpBellanger: I am thrilled to share a part of my PhD work, now published in Frontiers in Oncology. Here we report the existence and a…

03 Jul 2021

Reply Repost Favourite

I am thrilled to share a part of my PhD work, now published in Frontiers in Oncology. Here we report the existence and a possible biological role of a ZNF217 isoform in #breastcancer. #biomarker https://t.co/TxlmZBcWma

02 Jul 2021

Reply Repost Favourite

New research: Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer: Oncogene alternative splicing events can create distinct functional transcripts that offer new candidate prognostic biomarkers for… https://t.c

02 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.